Moderna, Inc. (MRNA) Discusses Intismeran mRNA Immunotherapy and Phase II KEYNOTE-942 Oncology Data Transcript
System1, Inc. (SST) Discusses Debt Exchange Agreement, Marketing Activity Reduction, and Long-Term Strategic Focus Transcript
Moderna, Inc. (MRNA) Discusses Intismeran mRNA Immunotherapy and Phase II KEYNOTE-942 Oncology Data - Slideshow (NASDAQ:MRNA) 2026-06-01
AstraZeneca PLC (AZN) Presents at American Society of Clinical Oncology (ASCO) Annual Meeting 2026 - Slideshow (NYSE:AZN) 2026-06-01
Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory Disease Transcript